For UK medicines regulation, refer to the MHRA.
Some researchers are exploring the potential for cyclical use of growth hormone or secretagogues, such as tesamorelin, under clinician guidance, to potentially improve immune function and increase IGF-1 levels, with one example being a cyclical cycle of tesamorelin to increase IGF-1 levels and measure its effects on the thymus and immune cell count 12m20s
The future of NAD+ research is likely to be shaped by advances in precision medicine and personalized research approaches that tailor NAD+ interventions to individual metabolic profiles and disease characteristics
Tissue Specificity and Metabolic Effects Importantly, these metabolic effects appear to be tissue-specific to adipose tissue, as studies have not shown similar effects on muscle protein metabolism or bone growth
For convenience and consistency, the 10mg vial makes more practical sense at maintenance doses